Molecular Targeted Therapeutic Modalities

View at publisher Summarise with VIRAT
Authors: Robert A. Copeland Ph.D
Cited by: 0
References: 74

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This chapter presents the various modalities of molecular targeted therapeutics. The chapter discusses two main categories of molecular targeted therapeutics: biologics and small-molecule drugs. Antibody-based therapeutics are presented as an exemplar of biologic therapeutic strategies. For small-molecule drugs, several targeted approaches are discussed including enzyme inhibitors and activators, receptor agonists and antagonists, proteolysis-targeting chimeras (PROTACs) and molecular glues, antibody–drug conjugates (ADCs), inducers and inhibitors of protein–protein interactions, correctors of protein misfolding and other modalities.

Fields of Study & Subjects

Protein Degradation and Inhibitors Monoclonal and Polyclonal Antibodies Research Computational Drug Discovery Methods

Publication details

Journal / source
Wiley eBooks
Pages
45–106
Publication date
27 March 2026
Language
EN
Document type
Book chapter